Simeon D, Guralnik O, Schmeidler J
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA.
J Trauma Stress. 2001 Apr;14(2):341-9. doi: 10.1023/A:1011169019614.
Our aim was to develop a clinician-rated scale assessing depersonalization severity for use in clinical trials of Depersonalization Disorder and trauma-related disorders in general. The 6-item Depersonalization Severity Scale (DSS) was administered to 63 participants with DSM-IV Depersonalization Disorder as diagnosed by the SCID-D, and its psychometric properties were examined. The sensitivity of the DSS and of the Dissociative Experiences Scale (DES) to treatment change was assessed in blinded, controlled settings. Individual items were widely distributed across the severity range. Interrater reliability was excellent and internal consistency was moderate. The DSS had high convergent and discriminant validity and was sensitive to treatment change. The DES was also sensitive to treatment change. We recommend piloting the DSS in future treatment trials of trauma-spectrum disorders.
我们的目标是开发一种由临床医生评定的量表，用于评估人格解体的严重程度，以用于人格解体障碍及一般创伤相关障碍的临床试验。对63名经SCID-D诊断为DSM-IV人格解体障碍的参与者施测了包含6个条目的人格解体严重程度量表（DSS），并对其心理测量特性进行了检验。在盲法对照环境中评估了DSS和分离体验量表（DES）对治疗变化的敏感性。各个条目在严重程度范围内分布广泛。评分者间信度极佳，内部一致性为中等。DSS具有较高的聚合效度和区分效度，且对治疗变化敏感。DES对治疗变化也很敏感。我们建议在未来创伤谱系障碍的治疗试验中试用DSS。
